LD-2 disclosure · 1st Quarter - Report
PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION
Client
- Description
- Informal coalition of health and consumer organizations and sunscreen industry companies
- Location
- District of Columbia · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
Implementation of the over the counter drug approval process reforms for sunscreen ingredients included in Public Law 116-136, the Coronavirus Aid, Relief, and Economic Secretary (CARES Act); issues related to sunscreen use and coral reefs; National Academies of Sciences study on sunscreen; FDA draft environmental impact statement regarding sunscreen; FDA proposed order on over-the-counter sunscreen ingredients; FY 2022 House and Senate appropriations for the Food and Drug Administration (H.R. 4356 and S. 2599); FY 2023 House and Senate appropriations for the Food and Drug Administration.
Lobbyistsmr RICHARD M GOLD · JOEL ROBERSON · MICHAEL WERNER · ETHAN JORGENSEN-EARP
TargetedSENATE · HOUSE OF REPRESENTATIVES